PTJ
VERA icon

Paul Tudor Jones’s Vera Therapeutics VERA Stock Holding History

Paul Tudor Jones’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,100
Closed -$2.54M – 4323
2025
Q4 		$2.54M Buy
+50,100
New +$1.78M ﹤0.01% 1636

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paul Tudor Jones's VERA Position: Q2 2025 in Review

Paul Tudor Jones sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 46,063 shares — an estimated $1.11M sold.

Paul Tudor Jones first reported a position in VERA in Q1 2024 and held it in 4 quarters. The position peaked at $1.63M in Q1 2024. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • Paul Tudor Jones reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 46,063 Vera Therapeutics shares in Q2 2025, an estimated $1.11M.
  • Paul Tudor Jones first reported a position in Vera Therapeutics in Q1 2024 and held it in 4 quarters.
  • Paul Tudor Jones's Vera Therapeutics position peaked at $1.63M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.